Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

A new framework for evaluating the health impacts of treatment for Gaucher disease type 1.

Ganz ML, Stern S, Ward A, Nalysnyk L, Selzer M, Hamed A, Weinreb N.

Orphanet J Rare Dis. 2017 Feb 20;12(1):38. doi: 10.1186/s13023-017-0592-6.

2.

Enzyme replacement and substrate reduction therapy for Gaucher disease.

Shemesh E, Deroma L, Bembi B, Deegan P, Hollak C, Weinreb NJ, Cox TM.

Cochrane Database Syst Rev. 2015 Mar 27;(3):CD010324. doi: 10.1002/14651858.CD010324.pub2. Review.

PMID:
25812601
3.

Management of Gaucher disease: enzyme replacement therapy.

Zimran A, Elstein D.

Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:82-7. Review.

PMID:
25345089
4.

Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment.

Weinreb NJ, Goldblatt J, Villalobos J, Charrow J, Cole JA, Kerstenetzky M, vom Dahl S, Hollak C.

J Inherit Metab Dis. 2013 May;36(3):543-53. doi: 10.1007/s10545-012-9528-4. Epub 2012 Sep 14. Erratum in: J Inherit Metab Dis. 2014 Jan;37(1):147.

5.

[Therapeutic targets in Gaucher's disease].

Giraldo P, Roca M.

Med Clin (Barc). 2011 Sep;137 Suppl 1:46-9. doi: 10.1016/S0025-7753(11)70017-3. Spanish.

PMID:
22230126
6.

The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause).

Zimran A, Morris E, Mengel E, Kaplan P, Belmatoug N, Hughes DA, Malinova V, Heitner R, Sobreira E, Mrsić M, Granovsky-Grisaru S, Amato D, vom Dahl S.

Blood Cells Mol Dis. 2009 Nov-Dec;43(3):264-88. doi: 10.1016/j.bcmd.2009.04.003. Epub 2009 Jun 6. Review.

PMID:
19502088
7.

Functional antibody deficiency in a patient with type I Gaucher disease.

Jariwala SP, Fodeman J, Hudes G, Ahuja K, Rosenstreich D.

J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S267-70. doi: 10.1007/s10545-008-0824-y. Epub 2008 Apr 4.

PMID:
18392747
8.

[Hematological aspects of Gaucher disease].

Costello R, O'Callaghan T, Baccini V, Sébahoun G.

Rev Med Interne. 2007 Oct;28 Suppl 2:S176-9. Review. French.

PMID:
18228684
9.

The outcome of clinical parameters in adults with severe Type I Gaucher disease using very low dose enzyme replacement therapy.

Wilson C, Spearing R, Teague L, Robertson P, Blacklock H.

Mol Genet Metab. 2007 Sep-Oct;92(1-2):131-6. Epub 2007 Jul 2.

PMID:
17604204
10.

Substrate reduction therapy of glycosphingolipid storage disorders.

Aerts JM, Hollak CE, Boot RG, Groener JE, Maas M.

J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):449-56.

PMID:
16763917
11.

Enzyme replacement therapy for Gaucher disease in Australia.

Goldblatt J, Szer J, Fletcher JM, McGill J, Rowell JA, Wilson M.

Intern Med J. 2005 Mar;35(3):156-61.

PMID:
15737135
12.

Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi.

Mariani G, Filocamo M, Giona F, Villa G, Amendola A, Erba P, Buffoni F, Copello F, Pierini A, Minichilli F, Gatti R, Brady RO.

J Nucl Med. 2003 Aug;44(8):1253-62.

13.

Rebound hepatosplenomegaly in type 1 Gaucher disease.

Tóth J, Erdos M, Maródi L.

Eur J Haematol. 2003 Feb;70(2):125-8.

PMID:
12581195
14.

Subarachnoid anesthesia in a patient with type I Gaucher disease.

García Collada JC, Pereda Marín RM, Martínez AI, Miralles Serrano EM, Pacheco López JF.

Acta Anaesthesiol Scand. 2003 Jan;47(1):106-9.

PMID:
12492809
15.

Type I Gaucher disease in children with and without enzyme therapy.

Dweck A, Abrahamov A, Hadas-Halpern I, Bdolach-Avram T, Zimran A, Elstein D.

Pediatr Hematol Oncol. 2002 Sep;19(6):389-97.

PMID:
12186361
16.

Cemented revision total hip arthroplasty with impaction bone grafting in Gaucher's disease.

George MD, Pearse MF.

J Arthroplasty. 2002 Aug;17(5):667-9.

PMID:
12168187
17.

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.

Weinreb NJ, Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Zimran A.

Am J Med. 2002 Aug 1;113(2):112-9.

PMID:
12133749
18.

Gaucher's disease and fatal hepatic fibrosis despite prolonged enzyme replacement therapy.

Perel Y, Bioulac-Sage P, Chateil JF, Trillaud H, Carles J, Lamireau T, Guillard JM.

Pediatrics. 2002 Jun;109(6):1170-3.

PMID:
12042560
19.

Response of Gaucher bone disease to enzyme replacement therapy.

Poll LW, Maas M, Terk MR, Roca-Espiau M, Bembi B, Ciana G, Weinreb NJ.

Br J Radiol. 2002;75 Suppl 1:A25-36. Review.

PMID:
12036830
20.

Supplemental Content

Loading ...
Support Center